EUVIMEDEUVIMED entdecken
Open Access

High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs

Emily M Lee, Steven A Titus, Miao Xu, Hengli Tang, Wei Zheng

ASSAY and Drug Development Technologies · 2019-04 · 17 (3) · 128-139

DOI: 10.1089/adt.2018.881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, online erschienen am 08.04.2019. Verfasst von Emily M Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Biological Science, Florida State University, Tallahassee, Florida. Hauptthemen laut MEDLINE: Drug Evaluation, Preclinical, High-Throughput Screening Assays. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zika virus has recently emerged as a worldwide pathogen and public health burden due to its rapid spread and identification as a causative agent for multiple neurological defects, including congenital microcephaly. While there has been a flurry of recent research to address this emerging pathogen, there are currently no approved drug treatments for ZIKV infection. The gold standard for testing antiviral activity is to quantify infectious virion production. However, current infectious viral production assays, such as the plaque-forming or focus-forming unit assay, are tedious and labor intensive with a low-screening throughput. To facilitate drug development, we developed a Zika viral titration assay using an automated imaging system and an image analysis algorithm for viral colony quantification. This assay retained the principle of the classical virus titer assay, while improving workflow and offering higher screening throughput. In addition, this assay can be broadly adapted to quantification of other viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Evaluation, PreclinicalHigh-Throughput Screening AssaysAlgorithmsAntiviral AgentsAutomationHumansMicrobial Sensitivity TestsOptical ImagingTumor Cells, CulturedViral LoadZika Virus

Stichwörter der Autor:innen

Zika virusantiviralcompound screeningfocus-forming unithigh throughputviral titer assay

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • 1 Department of Biological Science, Florida State University, Tallahassee, Florida.
  • 2 National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Lee, E. M., Titus, S. A., Xu, M., Tang, H., & Zheng, W. (2019). High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs. ASSAY and Drug Development Technologies, 17(3), 128-139. https://doi.org/10.1089/adt.2018.881

Vancouver

Lee EM, Titus SA, Xu M, Tang H, Zheng W. High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs. ASSAY and Drug Development Technologies. 2019;17(3):128-139. doi:10.1089/adt.2018.881

BibTeX
@article{Lee2019,
  author = {Lee, Emily M and Titus, Steven A and Xu, Miao and Tang, Hengli and Zheng, Wei},
  title = {High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral Drugs},
  journal = {ASSAY and Drug Development Technologies},
  year = {2019},
  volume = {17},
  number = {3},
  pages = {128--139},
  doi = {10.1089/adt.2018.881}
}
Kostenlos starten →